March 4, 2016 Via Email Mark Sumeray Dear Mark:Letter Agreement • May 16th, 2016 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations
As we have discussed, your employment with Aegerion Pharmaceuticals, Inc. (the “Company”) has terminated effective as of January 28, 2016 (the “Separation Date”). The purpose of this letter agreement (the “Agreement”) is to confirm the agreement between you and the Company concerning your separation from employment and severance benefits, as follows:
AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENTEmployment Agreement • May 16th, 2016 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This Amendment No. 2 to Employment Agreement (the “Second Amendment”) is made and entered into as of May 3, 2016 by and between Aegerion Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Gregory Perry (the “Employee”), and effective as of February 12, 2016. Capitalized terms not defined in this Second Amendment will have the meanings ascribed to them in the Employment Agreement (as defined below).
